Document is current
Any future updates will be listed below
-
Authors
Mancina, Rosellina M. https://orcid.org/0000-0002-1126-3071
Sasidharan, Kavitha https://orcid.org/0000-0003-3706-4692
Lindblom, Anna https://orcid.org/0000-0003-4903-1759
Wei, Ying
Ciociola, Ester
Jamialahmadi, Oveis
Pingitore, Piero
Andréasson, Anne-Christine
Pellegrini, Giovanni
Baselli, Guido https://orcid.org/0000-0002-0234-6828
Männistö, Ville
Pihlajamäki, Jussi https://orcid.org/0000-0002-6241-6859
Kärjä, Vesa
Grimaudo, Stefania
Marini, Ilaria
Maggioni, Marco
Becattini, Barbara
Tavaglione, Federica
Dix, Carly
Castaldo, Marie
Klein, Stephanie
Perelis, Mark
Pattou, Francois https://orcid.org/0000-0001-8388-3766
Thuillier, Dorothée
Raverdy, Violeta
Dongiovanni, Paola
Fracanzani, Anna Ludovica
Stickel, Felix
Hampe, Jochen https://orcid.org/0000-0002-2421-6127
Buch, Stephan https://orcid.org/0000-0003-2928-015X
Luukkonen, Panu K.
Prati, Daniele
Yki-Järvinen, Hannele
Petta, Salvatore
Xing, Chao https://orcid.org/0000-0002-1838-0502
Schafmayer, Clemens
Aigner, Elmar
Datz, Christian https://orcid.org/0000-0001-7838-4532
Lee, Richard G.
Valenti, Luca
Lindén, Daniel https://orcid.org/0000-0003-4158-8018
Romeo, Stefano https://orcid.org/0000-0001-9168-4898
- License Information
-
More Information
Article History
Received: 23 August 2021
Accepted: 8 December 2021
First Online: 31 January 2022
Competing interests
: A provisional patent application directed to the subject matter disclosed in this manuscript has been filed. A.L., A.-C.A., G.P., C. Dix, M.C. and D.L. are AstraZeneca employees. Y.W., S.K., M.P. and R.G.L. are Ionis Pharmaceuticals employees. S.R. has served as a consultant for AstraZeneca, Celgene, Sanofi, Amgen, Akcea Therapeutics, Camp4, Medacorp and Pfizer in the last 5 years. S.R. has received research grants from AstraZeneca, Sanofi and Amgen. L.V. reports having received speaking fees from MSD, Gilead, AlfaSigma, and AbbVie, having served as a consultant for Gilead, Pfizer, Astra Zeneca, Novo Nordisk, and having received research grants from Gilead. PKL was supported by the Novo Nordisk, Sigrid Jusélius and Instrumentarium Science Foundations. The remaining authors declare no competing interests.
